TRIB vs. BMRA, CDIO, OCX, MYMD, NAVB, ICCC, AWH, ABIO, VNRX, and GCTK
Should you be buying Trinity Biotech stock or one of its competitors? The main competitors of Trinity Biotech include Biomerica (BMRA), Cardio Diagnostics (CDIO), OncoCyte (OCX), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), ImmuCell (ICCC), Aspira Women's Health (AWH), ARCA biopharma (ABIO), VolitionRx (VNRX), and GlucoTrack (GCTK). These companies are all part of the "medical" sector.
Trinity Biotech (NASDAQ:TRIB) and Biomerica (NASDAQ:BMRA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, community ranking, analyst recommendations, valuation, media sentiment and institutional ownership.
79.0% of Trinity Biotech shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 8.2% of Trinity Biotech shares are owned by insiders. Comparatively, 13.5% of Biomerica shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Trinity Biotech has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Biomerica has a beta of -1.04, suggesting that its stock price is 204% less volatile than the S&P 500.
Trinity Biotech has a net margin of -42.26% compared to Biomerica's net margin of -117.46%. Trinity Biotech's return on equity of 0.00% beat Biomerica's return on equity.
Trinity Biotech received 181 more outperform votes than Biomerica when rated by MarketBeat users. Likewise, 70.98% of users gave Trinity Biotech an outperform vote while only 67.82% of users gave Biomerica an outperform vote.
Biomerica has lower revenue, but higher earnings than Trinity Biotech. Biomerica is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.
In the previous week, Trinity Biotech had 3 more articles in the media than Biomerica. MarketBeat recorded 5 mentions for Trinity Biotech and 2 mentions for Biomerica. Biomerica's average media sentiment score of 0.34 beat Trinity Biotech's score of -0.27 indicating that Biomerica is being referred to more favorably in the news media.
Summary
Trinity Biotech beats Biomerica on 10 of the 15 factors compared between the two stocks.
Get Trinity Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TRIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trinity Biotech Competitors List
Related Companies and Tools
